Primary |
Depression |
58.2% |
Anxiety |
21.8% |
Major Depression |
7.3% |
Disturbance In Attention |
3.6% |
Back Pain |
1.8% |
Drug Ineffective |
1.8% |
Headache |
1.8% |
Insomnia |
1.8% |
Panic Disorder |
1.8% |
|
Insomnia |
8.9% |
Paraesthesia |
8.9% |
Diarrhoea |
7.9% |
Nausea |
7.9% |
Weight Increased |
6.9% |
Nightmare |
5.9% |
Rash |
5.9% |
Tremor |
5.9% |
Hallucination |
5.0% |
Headache |
5.0% |
Off Label Use |
5.0% |
Vomiting |
5.0% |
Dizziness |
4.0% |
Palpitations |
4.0% |
Anxiety |
3.0% |
Restless Legs Syndrome |
3.0% |
Abnormal Dreams |
2.0% |
Accidental Exposure To Product |
2.0% |
Adverse Event |
2.0% |
Arthralgia |
2.0% |
|
Secondary |
Depression |
54.5% |
Major Depression |
18.2% |
Anxiety |
12.1% |
Insomnia |
9.1% |
Nervousness |
6.1% |
|
Weight Decreased |
18.8% |
Nightmare |
12.5% |
Somnolence |
12.5% |
Drug Effect Increased |
6.3% |
Nausea |
6.3% |
Pain In Extremity |
6.3% |
Palpitations |
6.3% |
Panic Attack |
6.3% |
Paraesthesia |
6.3% |
Paranoia |
6.3% |
Tinnitus |
6.3% |
Weight Increased |
6.3% |
|
Concomitant |
Multiple Sclerosis |
80.0% |
Postoperative Analgesia |
20.0% |
|
Paraesthesia |
50.0% |
Musculoskeletal Discomfort |
25.0% |
Supraventricular Tachycardia |
25.0% |
|